X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24705) 24705
Book Review (2556) 2556
Publication (2130) 2130
Newspaper Article (719) 719
Newsletter (207) 207
Conference Proceeding (76) 76
Book Chapter (58) 58
Magazine Article (51) 51
Trade Publication Article (28) 28
Book / eBook (10) 10
Paper (6) 6
Dissertation (4) 4
Reference (3) 3
Data Set (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21291) 21291
humans (15049) 15049
animals (8607) 8607
male (7867) 7867
female (7700) 7700
polyethylene glycols - chemistry (7278) 7278
pharmacology & pharmacy (7032) 7032
polyethylene glycol (6351) 6351
polyethylene glycols - therapeutic use (6315) 6315
middle aged (4442) 4442
nanoparticles (4252) 4252
adult (4175) 4175
mice (4120) 4120
interferon-alpha - therapeutic use (4088) 4088
drug delivery systems (3908) 3908
antiviral agents - therapeutic use (3827) 3827
treatment outcome (3542) 3542
cancer (3230) 3230
ribavirin - therapeutic use (3080) 3080
polyethylene glycols - administration & dosage (2956) 2956
hepatitis c, chronic - drug therapy (2815) 2815
analysis (2809) 2809
recombinant proteins (2754) 2754
drugs (2725) 2725
drug therapy, combination (2631) 2631
chemistry, multidisciplinary (2545) 2545
aged (2491) 2491
drug-delivery (2443) 2443
cell line, tumor (2400) 2400
polyethylene glycols (2383) 2383
rats (2316) 2316
gastroenterology & hepatology (2285) 2285
therapy (2217) 2217
particle size (2136) 2136
materials science, biomaterials (2074) 2074
recombinant proteins - therapeutic use (2021) 2021
vehicles (1990) 1990
in-vitro (1985) 1985
drug carriers - chemistry (1847) 1847
care and treatment (1794) 1794
health aspects (1736) 1736
polymers (1734) 1734
polyethylene glycols - adverse effects (1707) 1707
nanoparticles - chemistry (1691) 1691
proteins (1678) 1678
chemotherapy (1669) 1669
engineering, biomedical (1667) 1667
polyols (1651) 1651
poly (1615) 1615
micelles (1610) 1610
in-vivo (1594) 1594
hepatitis c (1568) 1568
oncology (1545) 1545
article (1536) 1536
solubility (1536) 1536
polyethylene glycols - pharmacology (1530) 1530
delivery (1529) 1529
research (1499) 1499
nanoscience & nanotechnology (1496) 1496
liposomes (1481) 1481
polyethylene-glycol (1476) 1476
tumors (1463) 1463
hepacivirus - genetics (1452) 1452
interferon (1444) 1444
ribavirin (1440) 1440
time factors (1435) 1435
genotype (1361) 1361
ethylene glycol (1347) 1347
medicine (1332) 1332
cells (1312) 1312
drug delivery (1293) 1293
hydrogels (1273) 1273
polymers - chemistry (1235) 1235
doxorubicin (1226) 1226
pharmacokinetics (1224) 1224
mice, inbred balb c (1211) 1211
polyethylene (1207) 1207
cell survival - drug effects (1198) 1198
drug therapy (1126) 1126
pharmacy (1121) 1121
toxicity (1083) 1083
biochemistry & molecular biology (1077) 1077
drug carriers (1061) 1061
antiviral agents - adverse effects (1027) 1027
interferon-alpha - adverse effects (1027) 1027
hepatitis c virus (1026) 1026
interferon-alpha - administration & dosage (1025) 1025
abridged index medicus (1022) 1022
nanotechnology (1014) 1014
cytotoxicity (1011) 1011
hepatitis c - drug therapy (1007) 1007
rats, sprague-dawley (1007) 1007
release (987) 987
doxorubicin - administration & dosage (978) 978
polyethylene glycols - pharmacokinetics (969) 969
biocompatibility (947) 947
biotechnology & applied microbiology (945) 945
peptides (945) 945
hydrogel (932) 932
hepatitis c, chronic - virology (929) 929
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24835) 24835
German (162) 162
Chinese (149) 149
Spanish (132) 132
French (104) 104
Japanese (93) 93
Russian (91) 91
Hungarian (36) 36
Polish (33) 33
Korean (29) 29
Italian (22) 22
Danish (12) 12
Portuguese (11) 11
Croatian (10) 10
Czech (8) 8
Dutch (8) 8
Norwegian (4) 4
Turkish (4) 4
Bulgarian (3) 3
Serbian (3) 3
Ukrainian (3) 3
Arabic (2) 2
Finnish (2) 2
Hebrew (2) 2
Romanian (2) 2
Slovak (2) 2
Swedish (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 13, pp. 1302 - 1308
Journal Article
Expert Opinion on Drug Delivery, ISSN 1742-5247, 11/2012, Volume 9, Issue 11, pp. 1319 - 1323
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 03/2015, Volume 10, pp. 1791 - 1804
Background: Effective anticancer drug delivery to the tumor site without rapid body clearance is a prerequisite for successful chemotherapy.... 
Phospholipid | Murine breast cancer chemotherapy | Nanoparticles PEG-b-PCL | Paclitaxel | nanoparticles PEG-b-PCL | paclitaxel | POLYMERIC MICELLE FORMULATION | CREMOPHOR-FREE | murine breast cancer chemotherapy | NANOSCIENCE & NANOTECHNOLOGY | GENEXOL-PM | PHASE-II TRIAL | PH-SENSITIVE LIPOSOMES | IN-VIVO | PHARMACOLOGY & PHARMACY | ANTICANCER DRUGS | phospholipid | CHAIN-LENGTH | TARGETED DELIVERY | Cell Survival - drug effects | Paclitaxel - pharmacology | Nanoparticles - chemistry | Polyethylene Glycols - pharmacokinetics | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Antineoplastic Agents - chemistry | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Polyethylene Glycols - therapeutic use | Lactones - pharmacology | Lactones - therapeutic use | Paclitaxel - chemistry | Animals | Lactones - pharmacokinetics | Nanoparticles - therapeutic use | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Mice | Drug Delivery Systems - methods | Lactones - chemistry | Polyethylene Glycols - pharmacology | Nanoparticles | Drugs | Usage | Drug delivery systems | Breast cancer | Research | Chemical properties | Drug therapy | Vehicles | Biomedical materials | Nuclear magnetic resonance--NMR | Polyethylene glycol | Efficiency | Lipids | FDA approval | Polymers | Cholesterol | Chromatography | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1195 - 1206
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 34 - 44
In this small, preliminary study of sofosbuvir, a nucleotide inhibitor of HCV polymerase, treatment with sofosbuvir and ribavirin, without peginterferon, was... 
GENOTYPE 1 | PSI-7977 | MEDICINE, GENERAL & INTERNAL | VIRUS-INFECTION | THERAPY | REPLICATION | RESISTANCE | REPLICON RNA-SYNTHESIS | COMBINATION | TREATMENT-NAIVE PATIENTS | PROTEASE | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Adult | Female | RNA, Viral - metabolism | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - isolation & purification | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Hemoglobins - metabolism | Genotype | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Interferon-alpha - adverse effects | Viral Nonstructural Proteins - antagonists & inhibitors | Sofosbuvir | Drugs | Dose-response relationship (Biochemistry) | Antiviral agents | Usage | Patient outcomes | Dosage and administration | Product/Service Evaluations | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Hepatitis | Interferon | Infections | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2013, Volume 159, Issue 2, pp. 86 - 96
Background: Telaprevir (TVR) plus peginterferon-alpha 2a (PEG-IFN-alpha 2a) and ribavirin substantially increases treatment efficacy for genotype 1 chronic... 
Vertex pharmaceuticals and janssen pharmaceuticals | MEDICINE, GENERAL & INTERNAL | COINFECTED PATIENTS | MANAGEMENT | RECOMMENDATIONS | PREDICTORS | BOCEPREVIR | HCV | UPDATE | VIROLOGICAL RESPONSE | ASSOCIATION | INTERFERON PLUS RIBAVIRIN | HIV-1 | Recombinant Proteins - therapeutic use | Antiviral Agents - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - pharmacokinetics | Recombinant Proteins - adverse effects | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Ribavirin - pharmacokinetics | Interferon-alpha - pharmacokinetics | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Double-Blind Method | Antiviral Agents - therapeutic use | Oligopeptides - pharmacokinetics | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Polyethylene Glycols - pharmacokinetics | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | HIV Infections - complications | Interferon-alpha - adverse effects | Antiviral agents | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Hepatitis C | Drug therapy | HIV infection | Drugs | Clinical trials | Hepatitis | Side effects | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article